Anulex Technologies, Inc. announced today the close of its third round of private equity financing, totaling approximately $20 million. New investors leading the round include MB Venture Partners (Memphis, TN) and Affinity Capital (Minneapolis, MN). Also participating in the financing are existing investors Split Rock Partners, New Enterprise Associates, Delphi Ventures and SightLine Partners.
Anulex Technologies, Inc. is a private company developing proprietary soft tissue repair products for the spine.
INFO SOURCES
Anulex Technologies, Inc.
FIRMS
Anulex Technologies, Inc. is a privately held company dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back pain afflicts four out of every five individuals at some point during their life, and it is a major cause of disability. Founded in 2001, Anulex has dedicated itself to the development of devices to improve spine surgical outcomes. To date, Anulex has raised approximately $38 million through three rounds of financing to support these efforts.
LINKED TO
Affinity Capital; Delphi Ventures; New Enterprise Associates (NEA); MB Venture Partners; Split Rock Partners; SightLine Partners
BOARD / MANAGEMENT
Gary D. Stevenson, Managing Partner of MB Venture Partners, will join Anulex's board of directors and Kristine Johnson, Managing Partner of Affinity Capital, will serve as a board observer.
TRADEMARKS
Inclose and Anulex are trademarks of Anulex Technologies, Inc.
Supporting Material
